LINKDOC CHINA SERIES
For more information on this topic, please see Oncology Clinical Data Anlaysis Systems Developer LinkDoc Completes Series B, MD 4/05/16 issue. LinkDoc has also partnered with Tianjin Chest Hospital to develop the first lung cancer AI-based medical diagnosis support platform in the Tianjin-Beijing-Hebei area.Įditor's Note: LinkDoc was set up in December 2014, and mainly focuses on developing information systems for oncology specialists, helping clinics, for example, to establish EMR systems which allow doctors to check information relating to their patients' diagnoses and treatment. According to Bloomberg, LinkDoc Technology Limited, a medical data platform company backed by Alibaba Group, plans to lead a 200 to 300 million financing round before its upcoming IPO in Hong Kong. As its data and technology resources have grown, the company has launched new AI-based diagnosis and treatment services and innovative pharmaceuticals industry services since early 2018. Zhang Tianze, CEO at LinkDoc, said that as of H1 2018 its medical big data platform covers approximately 60% of oncological disease types. The listing has already been approved by Nasdaq under the ticker ( LDOC). HONG KONG (Reuters) -Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States due to Beijing's clampdown on overseas listings by domestic firms, according. The Next Wave of AI Innovation with Microsoft Bing and Edge. The company did not disclose a specific value for its offering but listed it in the filing as 100 million, a placeholder figure typically used to. Participating in the round was sovereign wealth fund China Investment Corporation. The medical-data company LinkDoc Technology issued a prospectus on July 7 for a U.S. Chinese medical data company LinkDoc Technology filed paperwork on Monday to list shares in the US, as China’s digital healthcare industry continues to grow in the wake of the coronavirus pandemic. The company has participated in more than 300 real-world research projects, ranking first in China’s real-world research service industry with a market share of over 10%.Oncology Clinical Data Analysis Firm LinkDoc Wins RMB 1 Bln Series D iHeima, 7/04/18īeijing-based oncology-focused clinical data analysis systems developer LinkDoc Technology recently announced completion of RMB 1 bln in Series D funding in H1 2018. LinkDoc provides the single largest outsourcing remote care services that accumulatively conducted more than 4 million follow-up calls on behalf of hospital. The company has established the first real-world research cohort of lung cancer with large sample size in China, and built China’s first gynecological oncology data platform in cooperation with a team of well-known academicians in China. LinkDoc Technology is a domestic medical big data unicorn enterprise.
The company relies on regional data centers such as the National health medical data North Center to carry out data integration, management and application. Lianren Digital Health is a healthcare big data enterprise established by the joint efforts of National Health Commission and China Mobile. RF 2G781AAPerson holding smartphone with logo of Chinese data company LinkDoc Technology Limited on screen in front of website. This cooperation will expand the application scenarios of real-world data in clinical research, clinical recruitment and other fields, jointly promote the development of industry standards, and facilitate the digital transformation of the biopharmaceutical industry. AstraZeneca upgrades strategy on innovation ecosystem.
The two parties will launch an in-depth cooperation based on real-world data applications, and further establish a tumor data research demonstration application center.
Recently, LinkDoc Technology and Lianren Digital Health has signed a strategic cooperation agreement. LinkDoc Technology Ltd - Company Profile and News - Bloomberg Markets Live Now Bloomberg TV+ AI IRL:Why AI Is Critical to Deep Space Exploration Bloomberg Radio Meet the Press For over 60 years.
0 kommentar(er)
